NRGene Technologies Ltd. Logo

NRGene Technologies Ltd.

AI-powered genomic analysis software to accelerate and optimize plant and animal breeding.

NRGN | TA

Overview

Corporate Details

ISIN(s):
IL0011720716
LEI:
Country:
Israel
Address:
5 Golda Meir Street, 7403649 Ness Ziona
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

NRGene Technologies Ltd. is an agricultural technology (AgTech) company that develops and commercializes artificial intelligence-based software and genomic analysis tools. The company provides turn-key solutions that analyze large-scale genomic data to accelerate and optimize natural breeding processes for plants and animals. Its proprietary algorithms and platforms are utilized by leading breeding companies, seed developers, and agricultural organizations to enhance crop and livestock development, discover novel genetic traits, and improve food production sustainability. NRGene's core offerings include comprehensive genotyping solutions and genomic big data analytics designed to reveal genetic complexity and diversity.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-08-09 20:13
Regulatory News Service
Following the completion of its contracted two-year engagement under the Tel Av…
Hebrew (modern) 174.5 KB
2023-08-09 20:13
Business and Financial Review
Following the completion of its contracted two-year engagement under the Tel Av…
Russian 46.0 KB
2023-05-22 23:48
Management Discussion and Analysis
Analysis update report, target price remains 19.8 NIS
English 969.2 KB
2023-05-22 23:48
Earnings Release
Analysis update report, target price remains 19.8 NIS
Russian 70.9 KB
2023-04-13 20:31
Earnings Release
Analysis update - target price t is updated to NIS 19.8
English 959.3 KB
2023-04-13 20:31
Regulatory News Service
Analysis update - target price t is updated to NIS 19.8
Russian 67.3 KB
2022-12-11 20:51
Business and Financial Review
Analysis update report, target price remains 30.9NIS
English 1.1 MB
2022-12-11 20:51
Report Publication Announcement
Analysis update report, target price remains 30.9NIS
Russian 64.0 KB
2022-09-13 22:01
Investor Presentation
update Analysis (FROST) following financial report, target price remains NIS 30…
English 1.2 MB
2022-09-13 22:01
Report Publication Announcement
update Analysis (FROST) following financial report, target price remains NIS 30…
Russian 60.5 KB
2022-08-15 21:22
Investor Presentation
Investors Presentation - August 2022
English 2.5 MB
2022-08-15 21:22
Report Publication Announcement
Investors Presentation - August 2022
Russian 41.9 KB
2022-05-31 21:47
Investor Presentation
Analysis update report, target price remains 30.9NIS
English 1.1 MB
2022-05-31 21:47
Report Publication Announcement
Analysis update report, target price remains 30.9NIS
Russian 55.2 KB
2022-04-03 22:30
Regulatory News Service
Quarterly analysis update report, target price remains 30.9NIS
English 1.1 MB

Automate Your Workflow. Get a real-time feed of all NRGene Technologies Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for NRGene Technologies Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.